Author details

Full Name

David Klinkebiel

Affiliation

University of Nebraska Medical Center

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35754042	Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.	Oncogene	2022
35378132	Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells.	J Biol Chem	2022
34922631	MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB).	Acta Neuropathol Commun	2021
35128406	Stapling proteins in the RELA complex inhibits TNFÎ±-induced nuclear translocation of RELA.	RSC Chem Biol	2021
32404420	Endogenous oxidized DNA bases and APE1 regulate the formation of G-quadruplex structures in the genome.	Proc Natl Acad Sci U S A	2020
34888112	Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features.	Sci Bull (Beijing)	2020
32661313	Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection.	Nat Microbiol	2020
32508251	Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas.	Epigenetics	2020
32213861	Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability.	Cancers (Basel)	2020
32145124	MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).	Brain Pathol	2020
32497036	In vivoÂ modeling of metastatic human high-grade serous ovarian cancer in mice.	PLoS Genet	2020
30764732	Epigenetic activation of POTE genes in ovarian cancer.	Epigenetics	2019
31303884	Genetic Variants in Circadian Rhythm Genes and Self-Reported Sleep Quality in Women with Breast Cancer.	J Circadian Rhythms	2019
28282769	Epigenetic modifications of human placenta associated with preterm birth: a systematic review.	J Matern Fetal Neonatal Med	2018
30223016	Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy.	Cell Signal	2018
30459449	Expression of the POTE gene family in human ovarian cancer.	Sci Rep	2018
28794174	Maternal Western diet age-specifically alters female offspring voluntary physical activity and dopamine- and leptin-related gene expression.	FASEB J	2017
28288979	<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in mice.	Blood	2017
26743165	Epigenetic dysregulation of Insulin-like growth factor (IGF)-related genes and adverse pregnancy outcomes: a systematic review.	J Matern Fetal Neonatal Med	2016
27677595	Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice.	Sci Rep	2016
27589566	MIEN1 is tightly regulated by SINE Alu methylation in its promoter.	Oncotarget	2016
27690235	Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.	PLoS Genet	2016
27322684	PRAME expression and promoter hypomethylation in epithelial ovarian cancer.	Oncotarget	2016
27259716	DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.	Mol Cancer Res	2016
27134162	Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a.	Cell Rep	2016
25614448	Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.	Clin Cancer Res	2015
25639876	Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.	Oncogene	2015
25421677	Epigenetic approaches in glioblastoma multiforme and their implication in screening and diagnosis.	Methods Mol Biol	2015
24292811	Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis.	Leukemia	2014
23142381	HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.	Am J Pathol	2013
24001767	Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.	Mol Cell Biol	2013
23439431	Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors.	Sci Rep	2013
22133874	Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.	J Clin Invest	2012
21168523	5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating Î²-galactoside:Î±2,3-sialyltransferase 6 gene.	Int J Biochem Cell Biol	2011
19194464	Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.	Leukemia	2009
18373939	Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine.	Int J Biochem Cell Biol	2008
19022951	Biotinylation of histones represses transposable elements in human and mouse cells and cell lines and in Drosophila melanogaster.	J Nutr	2008
17706117	[Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].	Zhonghua Bing Li Xue Za Zhi	2007
16608647	[Promoter methylation and mRNA expression of APC gene in MCF10 breast cancer model].	Zhonghua Bing Li Xue Za Zhi	2006
15938832	[Promoter methylation and mRNA expression of MCF10 model cell lines of breast cancer].	Zhonghua Bing Li Xue Za Zhi	2005

1 - 40 of 40

Hui Shen

Van Andel Institute

Career Start Year 2010

Number of shared co-authors 0

Daniel D De Carvalho

Princess Margaret Cancer Centre, University Health Network

Career Start Year 2010

Number of shared co-authors 0

Benjamin G Barwick

Emory University School of Medicine

Career Start Year 2009

Number of shared co-authors 0

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 0

Yassen Assenov

German Cancer Research Center (DKFZ)

Career Start Year 2006

Number of shared co-authors 0

Henry Yang

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 0

Brock C Christensen

Geisel School of Medicine, Dartmouth College

Career Start Year 2005

Number of shared co-authors 0

Anderly C Chueh

Biomedicine Discovery Institute, Monash University

Career Start Year 2005

Number of shared co-authors 0

Duncan Sproul

Institute of Genetics and Cancer, University of Edinburgh

Career Start Year 2004

Number of shared co-authors 0

Jason S Lee

QIMR Berghofer Medical Research Institute

Career Start Year 2003

Number of shared co-authors 0

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Leslie Cope

Johns Hopkins University School of Medicine

Career Start Year 2003

Number of shared co-authors 0

Michael Slifker

Fox Chase Cancer Center

Career Start Year 2002

Number of shared co-authors 0

Robert Brown

Ovarian Cancer Action Research Centre, Imperial College London

Career Start Year 2002

Number of shared co-authors 1

Howard H Yang

Center for Cancer Research, National Cancer Institute

Career Start Year 2002

Number of shared co-authors 0

Yonghong Wang

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2001

Number of shared co-authors 0

Joyce E Ohm

Roswell Park Comprehensive Cancer Center

Career Start Year 1999

Number of shared co-authors 0

Michal R Schweiger

Institute for Translational Epigenetics, University of Cologne

Career Start Year 1999

Number of shared co-authors 0

Tim H-M Huang

University of Texas Health San Antonio (UTHSA)

Career Start Year 1997

Number of shared co-authors 0

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 1

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 0

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 0

Manon van Engeland

Maastricht University Medical Center

Career Start Year 1996

Number of shared co-authors 0

Martin Widschwendter

European Translational Oncology Prevention and Screening (EUTOPS) Institute

Career Start Year 1993

Number of shared co-authors 1

Jean-Pierre J Issa

Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine

Career Start Year 1993

Number of shared co-authors 0

Joseph F Costello

University of California san francisco

Career Start Year 1991

Number of shared co-authors 1

Holger Heyn

Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra

Career Start Year 1988

Number of shared co-authors 0

Peter W Laird

Van Andel Institute

Career Start Year 1985

Number of shared co-authors 0

Kornel E Schuebel

National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health

Career Start Year 1985

Number of shared co-authors 0

Christoph Plass

German Cancer Research Center

Career Start Year 1982

Number of shared co-authors 0

row(s) 1 - 30 of 30

Ronny Drapkin

University of Pennsylvania School of Medicine

Co-authored papers 3

Terese M Zidon

University of Missouri

Co-authored papers 1

Michael Matheny

American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School

Co-authored papers 1

Fernando Rodrigues-Lima

Universite Paris Cite, CNRS

Co-authored papers 1

Zied Abdullaev

Co-authored papers 1

Thomas E Childs

University of Missouri

Co-authored papers 1

Yap Ching Chew

Zymo Research Corporation

Co-authored papers 1